Travatan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Alerts
• Clinical Trials

Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients
Condition:   Primary Open Angle Glaucoma Interventions:   Drug: Latanoprost 0.005% Ophthalmic Solution;   Drug: Travoprost 0.004% ophthalmic solution;   Drug: Tafluprost Ophthalmic 0.0015% Ophthalmic Solution Sponsor:   Kasr El Aini Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2020 Category: Research Source Type: clinical trials

A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert
Condition:   Open Angle Glaucoma and Ocular Hypertension Intervention:   Drug: Ophthalmic Insert Sponsor:   Ocular Therapeutix, Inc. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2019 Category: Research Source Type: clinical trials